Interestingly, in the case of the commonly drugged PD-1/PD-L1 inhibitory pair, oral squamous cell carcinoma (OSCC) and meningioma exhibited low PD-1 receptor expression, while OSCC displayed elevated PD-L1 ligand levels alongside undetectable PD-1. This evidence concerns the gene CD274 and oral cavity squamous cell carcinoma.